Mynaric AG

  • WKN: A0JCY1
  • ISIN: DE000A0JCY11
  • Land: Deutschland

Nachricht vom 14.05.2021 | 08:00

Mynaric expands its U.S. Government team with former Airbus U.S., SES, and U.S. Air Force leader Tim Deaver

DGAP-News: Mynaric AG / Key word(s): Personnel
14.05.2021 / 08:00
The issuer is solely responsible for the content of this announcement.

May 14th, 2021, Washington, D.C. - Mynaric (Frankfurt Stock Exchange: M0Y, ISIN: DE000A0JCY11) has announced that Tim Deaver with over 30 years of experience with governmental space programs has been appointed VP Strategic Solutions.

Tim will operate out of Mynaric's newly established Washington, D.C. area office and will be responsible for creating and marketing customer solutions, particularly in response to the critical needs of the U.S. Department of Defense and other government clients. Prime among these will be the build out of the Space Development Agency's (SDA) Transport Layer Tranche 1 constellation of up to 150 satellites, each of which will feature between three to five optical terminals. The satellites are scheduled to be procured through an RFP to be issued by SDA in Q3 2021.
 

"I am absolutely delighted to welcome Tim to our team. He is an authority in the industry and has a proven track-record of successfully winning business from and providing valuable solutions for various parts of the U.S. Government. Laser communication is at an inflection point right now and the U.S. Government is playing a catalyzing role in transitioning the technology to industrial-scale deployment. Tim is joining just at the right time to allow us to leverage on that dynamic."
Tina Ghataore, CCO, Mynaric


Tim joins Mynaric from Airbus U.S. Space & Defense where he was Director of National Security Space Systems responsible for managing the company's U.S. Government space-related marketing, program capture, program management and customer liaison activities since 2018.

Prior to joining Airbus U.S., Tim worked for SES and SES Government Solutions for over 10 years where he led business and product development activities. At SES Government Services the team under his leadership won several high-profile opportunities including U.S. Air Force Space and Missile System Center Pathfinder 1 and 3 contracts, and commercially hosted research and navigation payloads for NASA and the FAA. Tim also served as the program manager and eventually the Program Executive for the U.S. Air Force's Commercially Hosted Infrared Payload (CHIRP). Prior to joining SES, Tim served 22 years in the U.S. Air Force in various space operational, intelligence, acquisition, and policy positions.
 

About Mynaric

Mynaric (Frankfurt Stock Exchange: M0Y, ISIN: DE000A0JCY11) produces the optical fiber for the skies and, as a pioneer of laser communication, enables extremely fast and secure wireless data transmission between aircraft, drones and satellites.

Globally, the need for fast, secure and ubiquitous network connectivity is advancing inexorably. Data networks such as the internet are now largely based on infrastructure on the ground which cannot be expanded arbitrarily for legal, economic or logistical reasons. The future, therefore, calls for an expansion of the existing network infrastructure into air and space. Mynaric pioneers this growth market with an industrialized approach to wireless laser communication products.

More information on: www.mynaric.com



14.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021